Please login to the form below

Nutraceuticals in India: A Challenging Opportunity

Published in eyeforpharma December 2016 by Marc Yates

As growth begins to plateau in more established territories, attention is turning to emerging markets with a fast-expanding middle class.One of these is India. It cannot quite compete with China for sheer volume of potential consumers: China has a population of around 1.38 billion compared with 1.31 billion in India, although the Indian population is expected to catch up by 2022...

http://www.researchpartnership.com/news/2017/01/nutraceuticals-in-india-a-challenging-opportunity/

25th January 2017

Share

Tags

Company Details

Research Partnership

+44 (0)20 8069 5000

Contact Website

Address:
Chester House
Fulham Green
81-83 Fulham High Street
London
SW6 3JW
United Kingdom

Latest content on this profile

Article: How behavioural economics can help you build better brand communications
For pharma marketers, accelerating brand performance means maximizing return on investment. Your campaigns need to trigger the right emotions, and the right actions, in your audience.
Research Partnership
Article: From KOLs to KOIs – How to identify and engage the new healthcare influencers
Paul Reed and Basil Feilding investigate a new breed of KOLs with online influence and explain why pharma needs to join the conversation.
Research Partnership
New syndicated patient reports -
Living with Uterine Fibroids and Endometriosis US 2022
Research Partnership
Webinar: From perceptions to prescribing: Combining forces with next-generation tracking and benchmarking to accelerate brand performance
Register to learn about Research Partnership and STEM Healthcare's new integrated approaches that give our clients the level of insights they need to accelerate brand performance.
Research Partnership
Animation: Living With
The journey from the patient's perspective
Research Partnership
Infographic: Therapy Watch Lupus
Download our latest infographic, which offers an introduction to the real-world patient insights collected by our Therapy Watch Lupus study.
Research Partnership